BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 37023836)

  • 1. Prediction and verification of the active ingredients and potential targets of Erhuang Quzhi Granules on non-alcoholic fatty liver disease based on network pharmacology.
    Li S; Wu X; Ma Y; Zhang H; Chen W
    J Ethnopharmacol; 2023 Jul; 311():116435. PubMed ID: 37023836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active ingredients of Erhuang Quzhi Granules for treating non-alcoholic fatty liver disease based on the NF-κB/NLRP3 pathway.
    Li S; Ma Y; Chen W
    Fitoterapia; 2023 Dec; 171():105704. PubMed ID: 37858757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncovering the mechanism of Huanglian-Wuzhuyu herb pair in treating nonalcoholic steatohepatitis based on network pharmacology and experimental validation.
    Zhang X; Gao R; Zhou Z; Sun J; Tang X; Li J; Zhou X; Shen T
    J Ethnopharmacol; 2022 Oct; 296():115405. PubMed ID: 35644437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on the action mechanism of the Polygonum perfoliatum L. on non-alcoholic fatty liver disease, based on network pharmacology and experimental validation.
    Liu G; Yang L; Tang Y; Lin J; Wang F; Shen J; Chang B; Kong X
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117330. PubMed ID: 37863399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
    Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
    J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Huanglian-Hongqu herb pair improves nonalcoholic fatty liver disease via NF-κB/NLRP3 pathway in mice: network pharmacology, molecular docking and experimental validation.
    Wang Z; Qiu H; Yang Y; Zhang Y; Mou T; Zhang X; Zhang Y
    Hereditas; 2024 Apr; 161(1):12. PubMed ID: 38566171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism of Chaenomelis Fructus in treatment of rheumatoid arthritis based on network pharmacology and experimental verification].
    Duan ZH; Jin C; Deng Y; Liu JL; Wang J; Li SG; Zhou Y
    Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(18):4852-4863. PubMed ID: 37802827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Ganshuang granules on non-alcoholic fatty liver and underlying mechanism: a network pharmacology and experimental verification.
    Guoguo Z; Bingjie S; Tianyan Z; Shaoxiu JI; Jingwei LI; Yanni D; Feng L; Dong W
    J Tradit Chin Med; 2024 Feb; 44(1):122-130. PubMed ID: 38213247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of Cynarine for treatment of non-alcoholic fatty liver disease based on the integration of network pharmacology, molecular docking and cell experiment.
    Sun CY; Yang LL; Zhao P; Yan PZ; Li J; Zhao DS
    Hereditas; 2022 Dec; 159(1):44. PubMed ID: 36451177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology, molecular docking and molecular dynamics simulation.
    Yang R; Yang H; Jiang D; Xu L; Feng L; Xing Y
    PeerJ; 2022; 10():e14171. PubMed ID: 36389420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network pharmacology-based prediction and verification of the active ingredients and potential targets of Huagan Decoction for reflux esophagitis.
    Zhao Y; Cao Y; Yang X; Guo M; Wang C; Zhang Z; Zhang Q; Huang X; Sun M; Xi C; Tangthianchaichana J; Bai J; Du S; Lu Y
    J Ethnopharmacol; 2022 Nov; 298():115629. PubMed ID: 35988839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network pharmacology combines machine learning, molecular simulation dynamics and experimental validation to explore the mechanism of acetylbinankadsurin A in the treatment of liver fibrosis.
    Peng W; Yang Y; Lu H; Shi H; Jiang L; Liao X; Zhao H; Wang W; Liu J
    J Ethnopharmacol; 2024 Apr; 323():117682. PubMed ID: 38169205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An herbal formulation "Shugan Xiaozhi decoction" ameliorates methionine/choline deficiency-induced nonalcoholic steatohepatitis through regulating inflammation and apoptosis-related pathways.
    Wang S; Chen B; Du R; Zhong M; Zhang C; Jin X; Cui X; Zhou Y; Kang Q; Xu H; Li Y; Wu Q; Tong G; Luo L
    J Ethnopharmacol; 2024 Jul; 329():118127. PubMed ID: 38583728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the molecular mechanism of Gan Shuang granules for the treatment of non-alcoholic steatohepatitis using network pharmacology, molecular docking, and experimental verification.
    Zhi G; Shao B; Zheng T; Mu J; Li J; Feng Y; Zhu S; Dang Y; Liu F; Wang D
    Front Pharmacol; 2023; 14():1082451. PubMed ID: 36762105
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular mechanism of Ginkgo biloba in treating type 2 diabetes mellitus combined with non-alcoholic fatty liver disease based on network pharmacology, molecular docking, and experimental evaluations.
    Xu S; Tang L; Qian X; Wang Y; Gong J; Yang H; Su D
    J Food Biochem; 2022 Dec; 46(12):e14419. PubMed ID: 36121703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of Xuebijing Injection in treatment of sepsis-associated ARDS based on network pharmacology and in vitro experiment].
    Ding WC; Chen J; Liao HY; Feng J; Wang J; Zhang YH; Ji XH; Chen Q; Wu XY; Sun ZR; Nie SN
    Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(12):3345-3359. PubMed ID: 37382018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Huangqin-Huanglian Decoction Protects Liver against Non-alcoholic Fatty Liver Disease in High Fat-diet Mice.
    Yang H; Wei D; Zhang Y; Jian W
    Endocr Metab Immune Disord Drug Targets; 2024; 24(6):691-708. PubMed ID: 37859322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jingfang granule alleviates Pseudomonas aeruginosa-induced acute lung inflammation through suppression of STAT3/IL-17/NF-κB pathway based on network pharmacology analysis and experimental validation.
    Gu M; Su W; Dai J; Wang J; Jia X; Yao J; Zhang G; Zhu Q; Pang Z
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116899. PubMed ID: 37454750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of Ganke Granules intervening acute lung injury based on network pharmacology and experimental verification].
    Liang H; Li XY; Zhang XW; Bao YW; Ding ML; Yuan QH; He CS; Zeng N
    Zhongguo Zhong Yao Za Zhi; 2024 Apr; 49(8):2197-2209. PubMed ID: 38812235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.